ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links0 made here, not in the record10 judgments2 judges (our rules as one)1 record change seen
Claude Opus 5.5Our rulesRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06380348JMT101 in Combination WithOsimertinib, VersusCisplatin-pemetrexed inParticipants With LocallyAdvanced or MetastaticNon-small Cell Lung Cancer(NSCLC) Characterized byShanghai JMT-Bio Inc.Phase 3 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSBecotatugEntry “JMT101 Injection”, read by our…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Our role rule · TestedTestedOsimertinibEntry “Osimertinib tablet”, read by o…›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Our role rule · TestedBackground · partnerCisplatinEntry “Cisplatin injection”, read by …›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Our role rule · ComparatorComparatorPemetrexedEntry “Pemetrexed injection”, read by…›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Our role rule · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Becotatug

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “JMT101 Injection”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3BecotatugClaude Opus 5.5TestedCurrent
Nov 3OsimertinibClaude Opus 5.5Background · partnerCurrent
Nov 3CisplatinClaude Opus 5.5ComparatorCurrent
Nov 3PemetrexedClaude Opus 5.5ComparatorCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Carcinoma, Non-Small-Cell LungOur condition-kind ruleFinest filed termCurrent
Nov 18BecotatugOur role ruleTestedAgrees
Nov 18OsimertinibOur role ruleTestedOverridden
Nov 18CisplatinOur role ruleComparatorAgrees
Nov 18PemetrexedOur role ruleComparatorAgrees
As of nowCarcinoma, Non-Small-Cell LungOur main-condition rule (R9)Main conditionCurrent